Evidence map›Paper›PMID 42107619›Full record

ArticleNeuroImage2026

Automated detection of cerebral microbleeds on ex-vivo MRI scans of community-based older adults.

Grant Nikseresht, Arnold M Evia, Gady Agam, David A Bennett, Julie A Schneider, Konstantinos Arfanakis

Abstract read
In one paragraph

Article in NeuroImage, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Grant NiksereshtDepartment of Computer Science, Illinois Institute of Technology, Chicago, IL, USA; Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA.
Arnold M EviaRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.
Gady AgamDepartment of Computer Science, Illinois Institute of Technology, Chicago, IL, USA.
David A BennettRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.
Julie A SchneiderRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.
Konstantinos ArfanakisDepartment of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA; Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA; Department of Diagnostic Radiology, Rush University Medical Center, Chicago, IL, USA. Electronic address: arfanakis@illinoistech.edu.

Funding

SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1991 to 2020
$49.1M
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGINGR01AG017917 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2001 to 2023
$43.3M
Rush Alzheimer's Disease Research CenterP30AG072975 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI Lisa L Barnes, Julie A. Schneider · 2021 to 2026
$24.7M
RISK FACTORS, PATHOLOGY, AND CLINICAL EXPRESSIONS OF ADR01AG015819 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1998 to 2024
$21.4M
Risk Factors for Cognitive Decline in African-AmericansR01AG022018 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BARNES, LISA L · 2004 to 2025
$18.2M
Characterizing TDP-43 related hippocampal degeneration and memory loss in agingR01AG067482 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI SCHNEIDER, JULIE A. · 2020 to 2024
$6.8M
Vascular-immune mechanisms of cerebral amyloid angiopathy and Alzheimer's pathologyRF1NS139975 · NINDS · J. DAVID GLADSTONE INSTITUTES · PI ARFANAKIS, KONSTANTINOS, BLURTON-JONES, MATHEW MARK · 2024 to 2024
$5.4M
MRI markers of brain aging and risk factors for cognitive decline in older African AmericansR01AG056405 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BARNES, LISA L · 2018 to 2023
$3.6M
Longitudinal validation of cerebral small vessel disease biomarkers in diverse community-based older adults without dementiaU01NS100599 · NINDS · RUSH UNIVERSITY MEDICAL CENTER · PI ARFANAKIS, KONSTANTINOS, SCHNEIDER, JULIE A. · 2023 to 2025
$3.5M
Multimodal MRI biomarkers of small vessel disease for older persons with and without dementia.UH3NS100599 · NINDS · RUSH UNIVERSITY MEDICAL CENTER · PI ARFANAKIS, KONSTANTINOS, SCHNEIDER, JULIE A. · 2018 to 2020
$3.5M
In-vivo MRI-based prediction of TDP43 pathology in agingR01AG064233 · NIA · ILLINOIS INSTITUTE OF TECHNOLOGY · PI ARFANAKIS, KONSTANTINOS, SCHNEIDER, JULIE A. · 2019 to 2023
$3.3M
Comprehensive Longitudinal Probabilistic Atlas of the Brain of Older Adults Without DementiaR01AG052200 · NIA · ILLINOIS INSTITUTE OF TECHNOLOGY · PI ARFANAKIS, KONSTANTINOS · 2016 to 2020
$2.5M
NIA NIH HHS P30 AG010161NIA NIH HHS P30 AG072975NIA NIH HHS R01 AG015819NIA NIH HHS R01 AG017917NIA NIH HHS R01 AG022018NIA NIH HHS R01 AG052200NIA NIH HHS R01 AG056405NIA NIH HHS R01 AG064233NIA NIH HHS R01 AG067482NINDS NIH HHS RF1 NS139975NINDS NIH HHS U01 NS100599NINDS NIH HHS UH3 NS100599
6 · The paper itself

Abstract

Cerebral microbleeds (CMBs) are small hemosiderin deposits visible on T2*-weighted MRI that have been associated with cerebrovascular pathology, cognitive decline, and increased stroke risk. While CMBs have been studied extensively in living populations, their relationship to neuropathology assessed at autopsy remains incompletely understood. Large-scale MRI-pathology studies are needed to clarify these associations, but manual annotation of CMBs on ex-vivo MRI is time-consuming and labor-intensive, creating a critical bottleneck. Automated detection of CMBs on ex-vivo MRI in community-based older adults is particularly challenging due to low CMB prevalence, abundant mimics (e.g. air bubbles), and limited training data. We present the first comprehensive automated detection algorithm for CMBs on ex-vivo T2*-weighted MRI from community-based older adults. Our approach combines a novel multi-echo synthesis algorithm with self-supervised pretraining using fuzzy segmentation and confidence-aware learning to address data scarcity and class imbalance. The method successfully captures 90% of definite CMBs (unambiguous hypointensities clearly within brain tissue) and 83% of all CMBs (definite and possible CMBs combined) at 15 false positives per scan in a dataset of 287 community-based older adults. This represents a 46% improvement in average precision over the baseline approach using only real data and establishes a benchmark for this challenging detection problem. The proposed system enables partially automated annotation workflows that reduce manual review burden by 5 to 20-fold compared to feature-based approaches, making large-scale MRI and pathology studies feasible.

Indexed as

BrainCerebral HemorrhageImage Interpretation, Computer-AssistedMagnetic Resonance ImagingAgedAged, 80 and overAlgorithmsFemaleHumansMaleBiomarkersEx-vivoMagnetic resonance imagingMicrobleedNeuropathology

Identifiers

PMID42107619
PMCPMC13243270

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.